Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Free Report

White Paper_2017_State of China Life Science

State of China Life Science - 2017H1

Over $10B invested in last 18 months! Download free report on life science investment in China.

Tianjin KingYork and Innovata Announce $190 Million Asthma JV

publication date: Jan 2, 2013
View a Printer Friendly version of this page, allowing you to print the page.
Tianjin KingYork Group Co. and Innovata HK Limited have formed a JV that will be located in Tianjin Economic-Technological Development Area (TEDA). The new company, which will be known as Tianjin Kinnovata Pharma, will produce powder inhalation drugs for asthma and COPD. The JV has been funded with $9.6 million initially. Over the longer term, the partners plan to invest $190 million in the project. The partners were advised by Morrison & Foerster, an international law firm specialized in life sciences, who also revealed that the JV expects to eventually attain revenues of more than 1 billion RMB ($160 million). More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China